LIU, Z.,
WANG, X.,
YANG, G.,
ZHONG, C.,
ZHANG, R.,
YE, J.,
ZHONG, Y.,
HU, J.,
OZAL, B.,
ZHAO, S. (2020) of their
mechanism of action in GBM. We downloaded data from The Cancer Genome Atlas (TCGA) and the Gene Expression
of DHMEQ. In the present review, we describe
mechanism of action, its in vivo anticancer activity
and telomeres; the impact on them is promising for the development of
mechanisms of lifespan regulation
of the
mechanisms contributing to the appearance of hypocalcemia affected
hypocalceuria in the midst of HFRS
GILYAZOVA, I.R.,
KLIMENTOVA, E.A.,
BERMISHEVA, M.A.,
KHUSNUTDINOVA, E.K.,
IZMAILOV, A.A.,
GALIMOVA, E.F.,
SAFIULLIN, R.I.,
GALIMOV, S.N.,
V.N. Pavlov,
BULYGIN, K.V. (2020) of microRNA-200c in tumour pathogenesis is rather contradictory, and the underlying
mechanisms by which